Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Corona Remedies Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Borrowings mainly consist of overdraft facilities linked to fixed deposits, amounting to INR 143 crores in FY26, with no traditional bank cash credit facility…
24 May 2026
Nazara Technologies Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
The recent acquisition of Bluetile (INR 1,460 crores revenue, INR 254 crores EBITDA in CY '25) will double Nazara’s EBITDA pro forma, adding significant scale…
24 May 2026
Welspun Living Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Domestic Indian market predicted to grow robustly at around 26% to 30%, driven by increased consumption and brand expansion. Key concall takeaways from Welspun…
24 May 2026
Afcons Infrastructure Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Order inflows will be a mix of approximately 60% domestic and 40% international orders, mainly from geographies where the company currently operates. Key…
24 May 2026
Paradeep Phosphates Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Although geopolitical and raw material supply uncertainties exist, PPL plans to maintain leadership and grow sales volumes, particularly in NPK, with 22%…
24 May 2026
Alivus Life Sciences Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
R&D spend is set to stabilize around 4% of sales, driving innovation in flow chemistry, high-potent APIs, pellets, and granules. Key concall takeaways from…
24 May 2026
Clean Max Enviro Energy Solutions Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Repeat business rate is high at around 74%, indicating strong customer retention and ongoing contracting. Key concall takeaways from Clean Max Enviro Energy…
24 May 2026
DOMS Industries Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
The company is commissioning a new plant on 45 acres, with total capex around INR 850-1,000 crores over 3 years. Key concall takeaways from DOMS Industries…
24 May 2026
JSW Dulux Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Strong volume growth of 23% was reported recently, with both decorative and industrial verticals contributing. Key concall takeaways from JSW Dulux Ltd's Q4…
24 May 2026
L T Foods Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
volume growth in FY26 was 38%; adjusted for Golden Star, net volume growth was 7% to 8%. Key concall takeaways from L T Foods Ltd's Q4 FY26 earnings call — and…
24 May 2026
V-Guard Industries Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
15% overall growth. Key concall takeaways from V-Guard Industries Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
24 May 2026
Devyani International Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
KFC showed strong momentum with a 4.9% positive same-store sales growth (SSSG) in Q4, supporting confidence in continued growth. Key concall takeaways from…
24 May 2026
Allied Blenders & Distillers Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
PET plant commissioned covering 70-75% of packaging requirements to reduce cost (Page 11). Key concall takeaways from Allied Blenders & Distillers's Q4 FY26…
24 May 2026
Alembic Pharmaceuticals Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
There will be continued, though measured, R&D investments (~INR 750-800 crores) to support complex products and expansion of the branded business. Key concall…
24 May 2026
Zydus Wellness Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Food & Nutrition (RiteBite): Continuing high growth momentum beyond the 25% CAGR pre-acquisition, driven by category expansion, new product launches (e.g., RTD…
24 May 2026
Cohance Lifesciences Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
They experienced healthy reload conversion above 90% and good new business conversions with innovator pharma and biotech customers. Key concall takeaways from…
24 May 2026
Sammaan Capital Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Asset Growth: Plans to grow AUM to INR 2 trillion by FY '30, with a mix of secured (60%) and unsecured (20%) lending. Key concall takeaways from Sammaan…
24 May 2026
Chalet Hotels Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Demand in the GCC (Greater Chennai Coimbatore) space is growing strongly at 30%-32% over the past 3-4 years with no sign of slowing down. Key concall takeaways…
24 May 2026
Redington Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
UAE grew 22% for full year, 6% in quarter despite Middle East war impact. Key concall takeaways from Redington Ltd's Q4 FY26 earnings call — and how it ranks…
24 May 2026
DCM Shriram Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Chemicals: Volumes and new product launches are driving growth; advanced materials and epoxy value chain growing well; new products now contribute ~34-35% of…
24 May 2026